Integra Lifesciences Holdings Revenue Growth Rates (IART), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Integra Lifesciences Holdings Corp  (NASDAQ: IART)
 

IART's Revenue Growth by Quarter and Year

Integra Lifesciences Holdings's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IART Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 418.76
1st Quarter March 391.92
FY 810.68

IARTs Annual Revenue
Integra Lifesciences Holdings's Revenue in the fiscal year 2025 $ 1,635.25 millions
Integra Lifesciences Holdings's Revenue in the fiscal year 2024 $ 1,610.53 millions
Integra Lifesciences Holdings's Revenue in the fiscal year 2023 $ 1,541.57 millions
Integra Lifesciences Holdings's Revenue in the fiscal year 2022 $ 1,557.67 millions
Integra Lifesciences Holdings's Revenue in the fiscal year 2021 $ 1,542.45 millions




IART Revenue second quarter 2026 Y/Y Growth Comment
Integra Lifesciences Holdings Corp reported Revenue growth of 0.76% year on year in the second quarter 2026, to $ 418.76 millions, this is lower than Integra Lifesciences Holdings Corp's recent average Revenue growth of 6.31%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 131 other companies have achieved higher Revenue growth. While Integra Lifesciences Holdings Corp' s Revenue increase of 0.76% ranks overall at the positon no. 2716 in the second quarter 2026.


IART Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - -1.74 % 11.49 % -0.25 %
3rd Quarter September - 5.57 % -0.42 % -0.72 %
2nd Quarter June 0.76 % -0.61 % 9.68 % -4.16 %
1st Quarter March 2.42 % 3.74 % -3.15 % 1.12 %
FY   - 1.53 % 4.47 % -

Financial Statements
Integra Lifesciences Holdings's second quarter 2026 Revenue $ 418.76 millions IART's Income Statement
Integra Lifesciences Holdings's second quarter 2025 Revenue $ 415.61 millions Quarterly IART's Income Statement


IART Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 8.18 % 16.23 % 3.82 %
3rd Quarter September - -3.26 % -8.93 % 0.3 %
2nd Quarter June 6.85 % 8.61 % 13.37 % 0.11 %
1st Quarter March -9.89 % -13.55 % -7.1 % -4.31 %
FY (Year on Year)   - 1.53 % 4.47 % -


Back to IART Growth rate Comparisons >> Back to IART Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #132
Healthcare Sector #386
Overall #2716

Revenue Y/Y Growth Statistics
High Average Low
50.77 % 6.31 % -32.58 %
(Sep 30 2018)   (Dec 31 2020)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #132
Healthcare Sector #386
Overall #2716
Revenue Y/Y Growth Statistics
High Average Low
50.77 % 6.31 % -32.58 %
(Sep 30 2018)   (Dec 31 2020)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Integra Lifesciences Holdings's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
43.13 % 1.92 % -27 %
(Sep 30 2020)  


IART's II. Quarter Q/Q Revenue Comment
Integra Lifesciences Holdings Corp achieved in the II. Quarter 2026 above company average sequential Revenue increase of 6.85%, to $ 418.76 millions, from $391.92 millions in the first quarter.

Within Medical Equipment & Supplies industry 37 other companies have achieved higher Revenue quarter on quarter growth. While Integra Lifesciences Holdings's Revenue growth quarter on quarter, overall rank is 974.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #38
Healthcare Sector #145
Overall #974
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #38
Healthcare Sector #145
Overall #974
Revenue Q/Q Growth Statistics
High Average Low
43.13 % 1.92 % -27 %
(Sep 30 2020)  


IART's II. Quarter Q/Q Revenue Comment
Integra Lifesciences Holdings Corp achieved in the II. Quarter 2026 above company average sequential Revenue increase of 6.85%, to $ 418.76 millions, from $391.92 millions in the first quarter.

Within Medical Equipment & Supplies industry 37 other companies have achieved higher Revenue quarter on quarter growth. While Integra Lifesciences Holdings's Revenue growth quarter on quarter, overall rank is 974.


Integra Lifesciences Holdings's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 1,647.67 $ 1,644.51 $ 1,635.25 $ 1,642.97 $ 1,621.74
Y / Y Revenue Growth (TTM) 1.6 % 1.24 % 1.53 % 4.99 % 3.53 %
Year on Year Revenue Growth Overall Ranking # 2112 # 1102 # 1293 # 2056 # 1946
Seqeuential Revenue Change (TTM) 0.19 % 0.57 % -0.47 % 1.31 % -0.16 %
Seq. Revenue Growth (TTM) Overall Ranking # 2482 # 1481 # 1935 # 1046 # 601


Cumulative Revenue growth Comment
Although Integra Lifesciences Holdings's Annual Revenue growth year on year were below company's average 5.97% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 1.6% year on year, from 1.24% in Mar 31 2026.

In the Healthcare sector 306 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1102 to 2112.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 132
Healthcare Sector # 307
Overall # 2112

Revenue TTM Y/Y Growth Statistics
High Average Low
35.57 %
 5.97 %
-9.6 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 132
Sector # 360
S&P 500 # 2482
Cumulative Revenue growth Comment
Although Integra Lifesciences Holdings's Annual Revenue growth year on year were below company's average 5.97% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 1.6% year on year, from 1.24% in Mar 31 2026.

In the Healthcare sector 306 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1102 to 2112.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 132
Healthcare Sector # 307
Overall # 2112

Revenue TTM Y/Y Growth Statistics
High Average Low
35.57 %
5.97 %
-9.6 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 132
Sector # 360
S&P 500 # 2482




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
IART's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue increase for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Icon Plc1.20%$ 1.197 millions
Bio techne Corp1.06%$ 1.063 millions
Tela Bio Inc 0.97%$ 0.974 millions
Integra Lifesciences Holdings Corp0.76%$ 0.759 millions
Icu Medical Inc0.66%$ 0.660 millions


About Integra Lifesciences Holdings Revenue Growth Rates (IART), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Integra Lifesciences Holdings Corp (CIK 917520).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0000917520-26-000058
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Integra Lifesciences Holdings Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.